Skip to main content
Dhan
Search
Search
Loading...
Scanning the Markets...

Home

Hexagon Nutrition Limited - Day 2: 4.60x Subscribed & GMP ₹7


Hexagon Nutrition Limited - Day 2: 4.60x Subscribed & GMP ₹7

Hexagon Nutrition Limited, a research-driven nutrition company, saw healthy demand on the second day of bidding for its initial public offering (IPO).

Fact Checked
Ridhima Gandhi
Ridhima Gandhi
|Jun 8, 2026, 06:33 PM
TelegramXLinkedIn
Add as a preferred source on Google
Hexagon Nutrition Limited - Day 2: 4.60x Subscribed & GMP ₹7


30-second summary:

  • The company is raising ₹138.87 crore via its IPO, which is a 100% Offer for Sale (OFS).
  • The bidding process began on June 5, 2026, and will end tomorrow, June 9, 2026.
  • Hexagon Nutrition exports to more than 75 countries and is a key supplier to United Nations food fortification programmes.
  • The IPO was oversubscribed at the end of Day 2, with an overall subscription of 4.60 times the shares offered.
  • The Grey Market Premium (GMP) is currently ₹7, which implies an estimated listing price of ₹57 per share.

Continuing its robust start, the public issue saw strong participation from retail and non-institutional investors, closing Day 2 with an overall subscription of 4.60 times and a Grey Market Premium (GMP) of ₹7.

The IPO offering is entirely an Offer for Sale (OFS) of 3.09 crore equity shares aggregating to ₹138.87 crore. The proceeds from the offering will not go directly to the company, as it is a pure OFS.

The momentum on Day 2 has been fuelled by a strong demand from retail investors and high-net-worth individuals. Hexagon Nutrition has been well-received primarily because of its proven history in the micronutrient segment, steady financial expansion, and global business diversification.

Here, we will be discussing what transpired on Day 2 of the Hexagon Nutrition Limited IPO.

Key Dates for the Hexagon Nutrition Limited IPO

Hexagon Nutrition IPO is currently in the bidding process, which opened on 5 June 2026 and will close on 9 June 2026. Post the closure of bids, the IPO allotment will be completed on Wednesday, 10 June 2026. Refund and credit of shares to demat accounts are scheduled from Thursday, 11 June 2026, and listing of shares is expected to happen on Friday, 12 June 2026, both on NSE and BSE.

The IPO is offered at a price range of ₹42 to ₹45 per share. Retail investors can apply for a minimum of 1 lot (333 shares), which would be ₹14,985 for the application. KFin Technologies Ltd is the registrar for the issue, while Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited are the book-running lead managers.

About Hexagon Nutrition Limited

Incorporated in 1993, Hexagon Nutrition Limited is headquartered in Nashik, Maharashtra, and possesses over 30 years of experience in health & wellness. The company is a leading player in its business segments, which include micronutrient premixes, therapeutic formulation, clinical nutrition, and ready-to-use foods with brands such as Pentasure, Obesigo, PediaGold, Nutrone, and others.

Hexagon Nutrition has 3 manufacturing plants in India, located at Nashik, Chennai, and Thoothukudi, respectively. Its manufacturing plant at Tashkent in Uzbekistan is its sole manufacturing plant outside India. Additionally, the company is the largest licensed producer of micronutrient powders in the world and also caters to leading FMCG companies in the market.

Financially, too, the company has been consistently growing; it recorded total income of ₹331.29 crore and its PAT almost doubled in FY25 to ₹24.38 crore. Its revenue stream has been stable with rising B2B and B2C penetration.

Recent GMP and Subscription Status on Day 2

As of the end of bidding on June 8, 2026 (Day 2), the overall IPO subscription was 4.60 times. Retail individual investors oversubscribed their reserved portion by 6.22 times. Non-Institutional Investors (NII) subscribed 6.70 times their quota, and Qualified Institutional Buyers (QIB) showed a muted response by subscribing only 0.17 times their quota.

In the unlisted market, the Grey Market Premium (GMP) was ₹7 on the day 2 end. This implies a positive listing at an estimated listing price of ₹52, with a 15.56% listing gain at the upper price band of ₹45. 

What’s next?

Hexagon Nutrition's integrated business model, global export presence, and improved profitability margins are cited as the reasons for the strong retail and NII subscription on Day 2. For long-term investors, the core appeal of this IPO lies in the company's ability to capitalise on India's booming wellness, clinical nutrition, and food fortification markets.

However, some investors are cautious due to its 100% OFS, as through IPO, the company will receive no funds for future growth and expansion. Additionally, the company also carries revenue concentration, with over 51% of its revenue coming only from its premix formulations segment.

With the last day of bidding (June 9) just around the corner, the spotlight will be on the Qualified Institutional Buyers (QIB) segment. As QIBs are known to rush in large numbers on the last day, which could further push the overall subscription count and stabilise the grey market premium ahead of the official listing on June 12.


fuzz
ipo banner

Read More on Ipo

Pre-apply for Upcoming IPOs